Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Unlocking the protective potential of the angiotensin type 2 receptor (AT2R) in acute lung injury and age-related pulmonary dysfunction

Biochemical Pharmacology(2023)10.1016/j.bcp.2023.115978Source: DataRank Database

Unlocking the protective potential of the angiotensin type 2 receptor (AT2R) in acute lung injury and age-related pulmonary dysfunction is a research paper published in Biochemical Pharmacology (2023). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.98)OA: greenTopics (35)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Çağlar Coşarderelioğlu ORCID,Mahendra Damarla ORCID,Alla Malinina,Dustin Dikeman ORCID,Ruth Marx

Live enrichment

PubMed:38081369 PMC:PMC10880333 OpenAlex:https://openalex.org/W4389503615

National Institute on Aging

Grant: P30AG021334

National Institutes of Health

Grant: R01AG046441

National Institutes of Health

Grant: RO1HL154343

NHLBI NIH HHS

Grant: R01 HL154343

FWCI

0.98

Citation Percentile

0.8%

Citation Trend

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10880333/pdf/nihms-1954583.pdf

publisherhttps://api.elsevier.com/content/article/PII:S0006295223005713?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0006295223005713?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10880333

Fields of Study

Neonatal Respiratory Health ResearchChronic Obstructive Pulmonary Disease (COPD) ResearchNeuroscience of respiration and sleepMiceAnimalsReceptor, Angiotensin, Type 2Angiotensin II Type 1 Receptor BlockersAngiotensin Receptor AntagonistsAngiotensin-Converting Enzyme InhibitorsReceptor, Angiotensin, Type 1Acute Lung Injury

MeSH Terms

Angiotensin-Converting Enzyme InhibitorsAnimalsReceptor, Angiotensin, Type 2Receptor, Angiotensin, Type 1Angiotensin II Type 1 Receptor BlockersMiceAcute Lung InjuryAngiotensin Receptor Antagonists

Keywords

Angiotensin IIOxidative stressLungHyperoxiaLosartanReceptorAgonistMedicineInternal medicineEndocrinologyAngiotensin receptorAcute Lung InjuryAngiotensin Type 2 ReceptorHyperoxic Acute Lung InjuryLung RasRenin-angiotensin Signaling System

Sustainable Development Goals

SDG 0: Good health and well-being

Unlocking the protective potential of the angiotensin type 2 receptor (AT2R) in acute lung injury and age-related pulmonary dysfunction

FAIR Checklist

Authors (10)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)